A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers

NCT01659554 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Principal Investigator left institution

Conditions

Recurrent Ovarian Cancer
Fallopian Tube Cancer

Interventions

DRUG: Cisplatin
DRUG: Doxorubicin

Sponsor

Columbia University